2nd Quarter - Amendment

AMERICAN SOCIETY OF CATARACT & REFRACTIVE SURGERY for AMERICAN SOCIETY OF CATARACT & REFRACTIVE SURGERY

Firm
Client
Income
—
Expenses
$91,640
Expense method
B: tax-exempt organisations, Internal Revenue Code section 6033(b)(8)

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing Filed Amount Counted
2nd Quarter - Report Jul 19, 2021 $91,640 Replaced
2nd Quarter - Amendment Jul 19, 2021 $91,640 Replaced
2nd Quarter - Amendment (this page) Jul 19, 2021 $91,640 Yes

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

Medicare reimbursement issues, Merit-Based Incentive Payment System (MIPS), advanced alternative payments models (APMs), Quality Payment Program (QPP), misvalued codes, ambulatory surgery centers, ophthalmic legislation, FDA-related issues, compounded drug issues, quality issues, off-label communication, health information technology, healthcare reform, health insurer anti-trust issues, prior authorization and step therapy, evaluation & management codes, add-on codes.

LobbyistCovered position, as disclosed
JILLIAN WINANS New —

Contacted: SENATE; Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); Centers For Medicare and Medicaid Services (CMS)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.